AS
HAE icon

Altshuler Shaham’s Haemonetics HAE Stock Holding History

Altshuler Shaham’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-726
Closed -$57.1K – 421
2022
Q4 		$57.1K Sell
726
-81
-10% -$6.51K ﹤0.01% 198
2022
Q3 		$59K Buy
+807
New +$57.9K ﹤0.01% 192
2021
Q2 		– Sell
-319
Closed -$35K – 660
2021
Q1 		$35K Buy
+319
New +$39.5K ﹤0.01% 349
2020
Q1 		– Sell
-117
Closed -$13K – 515
2019
Q4 		$13K Buy
117
+45
+63% +$5.45K ﹤0.01% 313
2019
Q3 		$9K Buy
+72
New +$9.14K ﹤0.01% 295
2019
Q1 		– Sell
-78
Closed -$8K – 318
2018
Q4 		$8K Buy
78
+15
+24% +$1.58K ﹤0.01% 196
2018
Q3 		$7K Buy
+63
New +$6.52K ﹤0.01% 205

Other funds holding HAE

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Altshuler Shaham's HAE Position: Q1 2023 in Review

Altshuler Shaham sold out of Haemonetics (HAE) in Q1 2023, closing a stake of 726 shares — an estimated $57.1K sold.

Altshuler Shaham first reported a position in HAE in Q3 2018 and held it in 7 quarters. The position peaked at $59K in Q3 2022. 301 funds tracked by Wall St. Rank hold HAE as of Q1 2023.

  • Altshuler Shaham reported no remaining Haemonetics position as of Q1 2023 after selling out during the quarter.
  • Altshuler Shaham sold 726 Haemonetics shares in Q1 2023, an estimated $57.1K.
  • Altshuler Shaham first reported a position in Haemonetics in Q3 2018 and held it in 7 quarters.
  • Altshuler Shaham's Haemonetics position peaked at $59K in Q3 2022.
  • 301 funds tracked by Wall St. Rank held Haemonetics as of Q1 2023.

Based on Altshuler Shaham's 13F filing for Q1 2023, filed 9 May 2023.